Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation  Almut Meyer-Bahlburg,

Slides:



Advertisements
Similar presentations
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Advertisements

Immacolata Brigida, PhD, Aisha V
Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination  Alberto Cagigi, PhD, Stefano Rinaldi, MSc,
The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency  Rita Carsetti, MD, Maria Manuela Rosado, PhD, Simona.
Risk of an asthma exacerbation after bariatric surgery in adults
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma  Alessia Scarselli, MD, Silvia Di Cesare, BSc, Gigliola Di Matteo,
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES)  Benedikt D. Spielberger, Cristina.
Defects of class-switch recombination
Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema  Sabine Zeller, MSc, Claudio Rhyner, PhD, Norbert Meyer, MD, Peter.
Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination  Alberto Cagigi, PhD, Stefano Rinaldi, MSc,
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome  Maria Carmina Castiello, PhD, Samantha.
Effect of rituximab on human in vivo antibody immune responses
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
CD4+ T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustion  Theresa Frenz, PhD, Elena Grabski, PhD, Daniela.
Immunologic defects in 22q11.2 deletion syndrome
Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production  Mark C. Glaum, MD, PhD, Shilpi Narula, MD, Decheng Song,
Analysis of somatic hypermutations in the IgM switch region in human B cells  Katsuyuki Horiuchi, MD, PhD, Kohsuke Imai, MD, PhD, Kanako Mitsui-Sekinaka,
IL-4 confers resistance to IL-27–mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling  Zhihong.
Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL- 23 receptor signaling and IL-17A production in patients with severe.
Jeff Choi, BSc, Rosemary Fernandez, PhD, Holden T
Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4+ and CD8+ T cells—clinical applications in primary immunodeficiency diagnostics 
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing.
CD19 controls Toll-like receptor 9 responses in human B cells
Heterotaxy syndrome with and without spleen: Different infection risk and management  Eva Piano Mortari, PhD, Anwar Baban, MD, PhD, Nicoletta Cantarutti,
Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis  Lena.
Comèl-Netherton syndrome defined as primary immunodeficiency
Treatment of chronic autoimmune urticaria with omalizumab
John-Paul Oliveria, BSc, Brittany M
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation  Esra.
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD,
Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1  Huan Zhang, MD, PhD, Colm E. Nestor, PhD, Shuli Zhao, PhD,
Defective B-cell memory in patients with Down syndrome
Sandra Hellberg, MSc, Ratnesh B
Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus–specific type 2 immune responses  Stephan Traidl, Petra Kienlin,
Alvin W. L. Schadenberg, MD, Theo van den Broek, MD, Marten A
Benjamin T. Prince, MD, Msci, Ashley L. Devonshire, MD, MPH, Kristin A
A. Wesley Burks, MD, Robert A. Wood, MD, Stacie M. Jones, MD, Scott H
Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis  Yuichi Teraki, MD, Misaki Kawabe, MD, Seiichi.
Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors  Donald W. MacGlashan, MD, PhD,
Serum free light chains in the differential diagnosis and prognosis of primary and secondary hypogammaglobulinemia  Nicolò Compagno, MD, Francesco Cinetto,
Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)  Kornvalee Meesilpavikkai,
What is an “eosinophilic phenotype” of asthma?
Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites  Zhikang Peng, MD, Andrew N. Beckett, BSc,
Dysregulated extracellular signal-regulated kinase signaling associated with impaired B- cell receptor endocytosis in patients with common variable immunodeficiency 
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?  Marianne Witten, MD, PhD, Hans-Jørgen Malling, MD, Lars.
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects  Polina Stepensky, MD,
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells  Troy R. Torgerson, MD,
TH9 immunodeficiency in patients with hyper-IgE syndrome
IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome 
Wasp venom immunotherapy expands a subpopulation of CD4+CD25+ forkhead box protein 3–positive regulatory T cells expressing the T-cell receptor Vβ2 and.
Biju Thomas, MD, Robert Anthony Hirst, PhD, Mina H
Common variable immunodeficiency as the initial presentation of dyskeratosis congenita  Eric J. Allenspach, MD, PhD, Cristian Bellodi, PhD, David Jeong,
Human BCR analysis of single-sorted, putative IgE+ memory B cells in food allergy  Rodrigo Jiménez-Saiz, PhD, Yosef Ellenbogen, BHSc, Kelly Bruton, BSc,
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
Reply Journal of Allergy and Clinical Immunology
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X- linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes 
Macrolide antibiotics and asthma treatment
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients  Suresh Pallikkuth, PhD, Sudheesh Pilakka.
Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D
Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis  David W. Morris, MD, Emily M. Stucke, BA, Lisa.
Increased immune reactivity to central nervous system–derived naturally presented peptides in patients with active multiple sclerosis  Christine Riedhammer,
Presentation transcript:

Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation  Almut Meyer-Bahlburg, MD, Ellen D. Renner, MD, Stacey Rylaarsdam, AS, Janine Reichenbach, MD, Lena F. Schimke, MD, Amy Marks, DO, Haig Tcheurekdjian, MD, Robert Hostoffer, DO, Archana Brahmandam, MS, Troy R. Torgerson, MD, PhD, Bernd H. Belohradsky, MD, David J. Rawlings, MD, Hans D. Ochs, MD  Journal of Allergy and Clinical Immunology  Volume 129, Issue 2, Pages 559-562.e2 (February 2012) DOI: 10.1016/j.jaci.2011.09.017 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Composition of the B-cell compartment in patients with STAT3-HIES. A, B-cell subpopulations obtained from staining strategy I (see Fig E1, A). Patients with HIES were divided into adult (≥20 years, n = 12) and young (age, 2.5-15 years; n = 13) groups. n.s., Not significant. B, Memory B-cell subsets based on staining strategy II (see Fig E1, B). ∗P ≤ .05, ∗∗P ≤ .01, and ∗∗∗P ≤ .001. Journal of Allergy and Clinical Immunology 2012 129, 559-562.e2DOI: (10.1016/j.jaci.2011.09.017) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 BAFF levels and BAFF-R expression in patients with STAT3-HIES and specific antibody production to bacteriophage phiX174. A, BAFF-R expression by CD19+ B cells shown as mean fluorescence intensity (MFI). B, Plasma BAFF levels were determined by means of ELISA. ∗∗∗P ≤ .001. C, BAFF levels and BAFF-R expression in patients with HIES correlate negatively. D, Positive correlation between plasma BAFF levels and NIH HIES scores. E, Peak antibody titers expressed as the rate of phage inactivation (K value [Kv]) observed in 6 patients with STAT3-HIES after primary and secondary immunization with the neoantigen bacteriophage phiX174, which was injected twice 6 weeks apart. Kv was plotted on a log scale. Individual patients are identified by symbols. Solid lines present geometric means and 96% CIs measured in 57 healthy control subjects. F, The mean percentage of phage-specific IgG antibody determined 2 weeks after the second immunization as antibody resistant to treatment with 2-mercaptoethanol, as indicated for each patient with HIES (percentage of 57 healthy control subjects: 50.6% ± 34.2% 2 SDs). Journal of Allergy and Clinical Immunology 2012 129, 559-562.e2DOI: (10.1016/j.jaci.2011.09.017) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Example of B-cell staining: 1 healthy control subject and 1 representative patient with STAT3-HIES (patient no. 15.2). A, Staining strategy I: immature, mature, and memory B cells (CD19+) were identified based on CD38 and CD24 expression. Memory B cells were further differentiated into unswitched (IgM+) and switched (IgM−) memory B cells. B, Staining strategy II: CD27+ memory B cells were gated into IgG+, IgA+, or IgG−IgA− memory B cells. C, Expression of BAFF-R by CD19+ B cells. Journal of Allergy and Clinical Immunology 2012 129, 559-562.e2DOI: (10.1016/j.jaci.2011.09.017) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions